Loading
What changed between revision 2 and revision 3, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 2
Import
Re-import of content/germline-editing.md — the file changed after the initial import. Not an edit.
19.3 kB
Revision 2
Revision 3
lines 8–14 → 8–147 unchanged lines not shown
categories: ["genetics", "society", "reproduction"]categories: ["genetics", "society", "reproduction"]tags: ["crispr", "embryos", "heritable editing", "bioethics", "governance", "reproduction"]tags: ["crispr", "embryos", "heritable editing", "bioethics", "governance", "reproduction"]summary: "Modification of human embryos, eggs, or sperm so that the genetic change is inherited by the resulting child and by all of their descendants."summary: "Modification of human embryos, eggs, or sperm so that the genetic change is inherited by the resulting child and by all of their descendants."updated: "2026-08-23"updated: "2026-10-29"humanEvidence: "One unsanctioned clinic case produced children from CCR5-edited embryos in 2018 and 2019; all other human work is in research embryos cultured for days, where editing is frequently mosaic and can delete or lose the target chromosome."humanEvidence: "One unsanctioned clinic case produced children from CCR5-edited embryos in 2018 and 2019; all other human work is in research embryos cultured for days, where editing is frequently mosaic and can delete or lose the target chromosome."access: "Obtainable through no lawful route: transfer of an edited embryo to a womb is forbidden wherever the question is regulated, and research use is confined to licensed embryo work."access: "Obtainable through no lawful route: transfer of an edited embryo to a womb is forbidden wherever the question is regulated, and research use is confined to licensed embryo work."reversibility: "irreversible"reversibility: "irreversible"lines 34–51 → 34–5119 unchanged lines not shown
## Definition and scope## Definition and scope The germ line is the cell lineage that produces eggs and sperm. Edits made anywhere else — in liver, muscle, blood, retina — die with the patient, which is why [[somatic-gene-therapy]] is regulated as ordinary medicine and heritable editing is not regulated as medicine at all in most countries but prohibited outright.The germ line is the cell lineage that produces eggs and sperm. Edits made anywhere else (in liver, muscle, blood, retina) die with the patient, which is why [[somatic-gene-therapy]] is regulated as ordinary medicine and heritable editing is not regulated as medicine at all in most countries but prohibited outright. The boundary is less crisp than the vocabulary suggests. Editing spermatogonial stem cells in an adult man is technically somatic but heritable in effect. [[mitochondrial-replacement-therapy]], legal in the United Kingdom since 2015 and used there in births reported in 2025, alters the mitochondrial genome transmitted down the maternal line; it is heritable, yet it was legislated as an exception rather than treated as germline modification, on the argument that it swaps an organelle rather than editing nuclear DNA. Whether that distinction is principled or convenient remains disputed.The boundary is less crisp than the vocabulary suggests. Editing spermatogonial stem cells in an adult man is technically somatic but heritable in effect. [[mitochondrial-replacement-therapy]], legal in the United Kingdom since 2015 and used there in births reported in 2025, alters the mitochondrial genome transmitted down the maternal line; it is heritable, yet it was legislated as an exception rather than treated as germline modification, on the argument that it swaps an organelle rather than editing nuclear DNA. Whether that distinction is principled or convenient remains disputed. Two further clarifications matter. Germline editing is not embryo selection. Selection chooses among embryos that already exist and cannot introduce a variant that no embryo has; [[embryo-selection]] and [[polygenic-embryo-screening]] work entirely within the range of what a given couple's gametes happen to produce. Editing writes something new. And germline editing is not cloning: [[human-cloning]] copies a genome, whereas editing changes one.Two further clarifications matter. Germline editing is not embryo selection. Selection chooses among embryos that already exist and cannot introduce a variant that no embryo has; [[embryo-selection]] and [[polygenic-embryo-screening]] work entirely within the range of what a given couple's gametes happen to produce. Editing writes something new. And germline editing is not cloning: [[human-cloning]] copies a genome, whereas editing changes one. > [!note] Terminology> [!note] Terminology> Scientific bodies increasingly prefer "heritable human genome editing" to "germline editing", because the term names the consequence — inheritance by descendants — rather than the tissue, and so covers edge cases like gamete precursor cells and mitochondrial transfer.> Scientific bodies increasingly prefer "heritable human genome editing" to "germline editing", because the term names the consequence (inheritance by descendants) rather than the tissue, and so covers edge cases like gamete precursor cells and mitochondrial transfer. ## How it would be done## How it would be done The procedure would sit inside a standard IVF cycle. Eggs are retrieved and fertilised; the editing reagents — most plausibly a [[crispr-cas9]] ribonucleoprotein, a [[base-editing]] complex, or a [[prime-editing]] system, the last two avoiding the double-strand break that a nuclease necessarily makes — are introduced into the zygote by microinjection or electroporation, ideally at or before fertilisation so that editing precedes the first cell division. The embryo is cultured for several days, a few trophectoderm cells are biopsied and sequenced, and an embryo judged correctly edited is transferred.The procedure would sit inside a standard IVF cycle. Eggs are retrieved and fertilised, and the editing reagents are introduced into the zygote by microinjection or electroporation, ideally at or before fertilisation so that editing precedes the first cell division. The reagent would most plausibly be a [[crispr-cas9]] ribonucleoprotein, a [[base-editing]] complex, or a [[prime-editing]] system, the last two avoiding the double-strand break that a nuclease necessarily makes. The embryo is cultured for several days, a few trophectoderm cells are biopsied and sequenced, and an embryo judged correctly edited is transferred. ```figure```figure{"key": "icsi-microinjection", "caption": "Intracytoplasmic sperm injection, the micromanipulation germline editing would piggyback on: editing reagents are delivered by the same kind of needle at or shortly after fertilisation, one egg at a time."}{"key": "icsi-microinjection", "caption": "Intracytoplasmic sperm injection, the micromanipulation germline editing would piggyback on: editing reagents are delivered by the same kind of needle at or shortly after fertilisation, one egg at a time."}lines 53–65 → 53–651 unchanged line not shown
Every step of that description contains an unsolved problem, and the biopsy step contains the deepest one.Every step of that description contains an unsolved problem, and the biopsy step contains the deepest one. An alternative entry point would avoid several of them. Editing gamete precursor cells — spermatogonial stem cells in a testis, or oocyte precursors derived in culture — allows the edited cell population to be expanded, sequenced exhaustively, and selected before any embryo exists. Nothing would then be mosaic, and verification would no longer destroy the thing verified. Human spermatogonial culture is difficult and human oogenesis in vitro has not been achieved, so this route remains theoretical; it is nonetheless the version of heritable editing that has the fewest intrinsic technical objections, and it is the one that [[in-vitro-gametogenesis]] research would make possible if it succeeds.An alternative entry point would avoid several of them. Editing gamete precursor cells (spermatogonial stem cells in a testis, or oocyte precursors derived in culture) allows the edited cell population to be expanded, sequenced exhaustively, and selected before any embryo exists. Nothing would then be mosaic, and verification would no longer destroy the thing verified. Human spermatogonial culture is difficult and human oogenesis in vitro has not been achieved, so this route remains theoretical; it is nonetheless the version of heritable editing that has the fewest intrinsic technical objections, and it is the one that [[in-vitro-gametogenesis]] research would make possible if it succeeds. ## Technical obstacles## Technical obstacles ### Mosaicism### Mosaicism Editing reagents remain active after the zygote divides. If the first cut occurs at the two- or four-cell stage, the resulting embryo is a mixture of edited, unedited, and differently edited cells. A biopsy samples five to ten cells from the trophectoderm — tissue that becomes placenta, not fetus — and so provides a sample of a mosaic, not a description of the child. Injecting reagents earlier reduces but does not abolish the problem.Editing reagents remain active after the zygote divides. If the first cut occurs at the two- or four-cell stage, the resulting embryo is a mixture of edited, unedited, and differently edited cells. A biopsy samples five to ten cells from the trophectoderm, the tissue that becomes placenta rather than fetus, so it samples a mosaic instead of describing the child. Injecting reagents earlier reduces but does not abolish the problem. ### On-target damage### On-target damage lines 75–92 → 75–929 unchanged lines not shown
### The claim that has already collapsed once### The claim that has already collapsed once A 2017 report claimed that human embryos repaired an inherited cardiomyopathy mutation by copying the healthy maternal allele, which if true would have offered a template-free route to correction.[^ma2017] Other groups argued the apparent correction was more likely allele dropout — the mutant allele deleted and therefore invisible — and the interpretation was contested in the literature.[^egli2018] The episode is a standing reminder that embryo genotyping is unusually easy to get wrong.A 2017 report claimed that human embryos repaired an inherited cardiomyopathy mutation by copying the healthy maternal allele, which if true would have offered a template-free route to correction.[^ma2017] Other groups argued the apparent correction was more likely allele dropout, with the mutant allele deleted and therefore invisible, and the interpretation was contested in the literature.[^egli2018] The episode is a standing reminder that embryo genotyping is unusually easy to get wrong. > [!caution] Contested> [!caution] Contested> No published work demonstrates accurate, complete, non-mosaic editing of a human embryo verified to the standard that clinical use would require. The 2020 international commission treated establishing such a demonstration as a precondition even to begin discussing translation.[^ihgge2020]> No published work demonstrates accurate, complete, non-mosaic editing of a human embryo verified to the standard that clinical use would require. The 2020 international commission treated establishing such a demonstration as a precondition even to begin discussing translation.[^ihgge2020] ## When editing would beat selection## When editing would beat selection The strongest argument against germline editing is not that it is dangerous but that it is usually unnecessary. For nearly every couple at risk of transmitting a serious monogenic condition, preimplantation genetic testing identifies an unaffected embryo among those already produced. Editing adds risk without adding capability.The strongest argument against germline editing is that it is usually unnecessary rather than that it is dangerous. For nearly every couple at risk of transmitting a serious monogenic condition, preimplantation genetic testing identifies an unaffected embryo among those already produced. Editing adds risk without adding capability. The 2020 report of the International Commission convened by the US National Academies and the UK Royal Society identified the residual cases. They are few:The 2020 report of the International Commission convened by the US National Academies and the UK Royal Society identified the residual cases. They are few: - Both prospective parents homozygous for the same recessive condition — for example both living with sickle cell disease — so that every embryo they can produce is affected.- Both prospective parents homozygous for the same recessive condition, for example both living with sickle cell disease, so that every embryo they can produce is affected.- One parent homozygous for a dominant condition, a rare situation in disorders such as Huntington's disease.- One parent homozygous for a dominant condition, a rare situation in disorders such as Huntington's disease.- Couples for whom testing is possible in principle but who reliably obtain very few embryos, or none unaffected, across repeated cycles.- Couples for whom testing is possible in principle but who reliably obtain very few embryos, or none unaffected, across repeated cycles. lines 109–115 → 109–11516 unchanged lines not shown
Wherever the question is regulated at all, the law splits at the moment of transfer. Editing embryos in a dish is permitted, under licence or under guidelines, in the United Kingdom, China, Japan, and the United States; placing an edited embryo in a uterus is what is forbidden. Research embryos are separately bound by the fourteen-day culture limit that most jurisdictions and professional guidelines impose, which ends every experiment long before any developmental consequence of an edit could be seen. The evidence base is therefore capped by law at the first fortnight of development, for a technology whose consequences would play out over a lifetime and beyond it.Wherever the question is regulated at all, the law splits at the moment of transfer. Editing embryos in a dish is permitted, under licence or under guidelines, in the United Kingdom, China, Japan, and the United States; placing an edited embryo in a uterus is what is forbidden. Research embryos are separately bound by the fourteen-day culture limit that most jurisdictions and professional guidelines impose, which ends every experiment long before any developmental consequence of an edit could be seen. The evidence base is therefore capped by law at the first fortnight of development, for a technology whose consequences would play out over a lifetime and beyond it. The instruments doing the forbidding differ in strength, and that variation matters more than the headline count of countries. Some are criminal statutes with stated penalties. Others are clauses in assisted-reproduction acts drafted before editing existed, ministry guidelines with no sanction attached, or — as in the United States — an appropriations rider that bars the Food and Drug Administration from acknowledging an application involving a heritable modification, closing the licensing route without creating any offence. A country can appear on a list of jurisdictions that prohibit heritable editing while having nothing a prosecutor could actually charge.[^baylis2020] The instrument-by-instrument picture, and the treaties that sit above it, are set out in [[governance-of-genome-editing]].The instruments doing the forbidding differ in strength, and that variation matters more than the headline count of countries. Some are criminal statutes with stated penalties. Others are clauses in assisted-reproduction acts drafted before editing existed, ministry guidelines with no sanction attached, or, as in the United States, an appropriations rider that bars the Food and Drug Administration from acknowledging an application involving a heritable modification, closing the licensing route without creating any offence. A country can appear on a list of jurisdictions that prohibit heritable editing while having nothing a prosecutor could actually charge.[^baylis2020] The instrument-by-instrument picture, and the treaties that sit above it, are set out in [[governance-of-genome-editing]]. Professional self-governance has done the rest of the work: the 2015 commentary in which [[jennifer-doudna]] and co-authors urged that clinical germline use be discouraged while the research questions were settled,[^baltimore2015] then the three international summits, the academies' reports, and the World Health Organization's 2021 recommendations, which ask member states to treat clinical germline use as prohibited and establish a registry for genome-editing research.[^who2021] Its instruments are soft: statements, licensing conditions, funder policies, journal refusals. None carries enforcement power. On the one occasion the line was crossed, every consequence came from a Chinese criminal court applying a statute about practising medicine without a licence, which had nothing to do with genetics.Professional self-governance has done the rest of the work: the 2015 commentary in which [[jennifer-doudna]] and co-authors urged that clinical germline use be discouraged while the research questions were settled,[^baltimore2015] then the three international summits, the academies' reports, and the World Health Organization's 2021 recommendations, which ask member states to treat clinical germline use as prohibited and establish a registry for genome-editing research.[^who2021] Its instruments are soft: statements, licensing conditions, funder policies, journal refusals. None carries enforcement power. On the one occasion the line was crossed, every consequence came from a Chinese criminal court applying a statute about practising medicine without a licence, which had nothing to do with genetics. lines 120–128 → 120–1284 unchanged lines not shown
### The slope argument### The slope argument Nothing in the technique distinguishes correcting a disease allele from installing an advantageous one. The 2018 case is the empirical data point: the twins had no disease, and the edit was intended to confer resistance to an infection they might never encounter — prophylaxis or enhancement, not treatment. Critics of a therapeutic pathway argue that the same clinics, techniques, and consent forms would carry enhancement requests, and that the demand exists whether or not the science supports it.Nothing in the technique distinguishes correcting a disease allele from installing an advantageous one. The 2018 case is the empirical data point: the twins had no disease, and the edit was intended to confer resistance to an infection they might never encounter, which is prophylaxis or enhancement rather than treatment. Critics of a therapeutic pathway argue that the same clinics, techniques, and consent forms would carry enhancement requests, and that the demand exists whether or not the science supports it. The science mostly does not. Variants with large, well-understood, unambiguously beneficial effects are rare; most traits people would want to change are influenced by thousands of variants of tiny effect, so [[genetic-enhancement-of-intelligence]] by editing is not a near-term prospect regardless of legality. Even apparently simple protective variants carry pleiotropic costs: disrupting CCR5 confers partial HIV resistance and also increases susceptibility to West Nile virus. The realistic near-term enhancement worry is not superhuman children but confident intervention on the basis of incomplete genetics, an error mode that [[designer-babies]] discussions frequently understate and that ethicists working on [[procreative-beneficence]] and [[disability-rights-and-enhancement]] have examined from opposite directions.The science mostly does not. Variants with large, well-understood, unambiguously beneficial effects are rare; most traits people would want to change are influenced by thousands of variants of tiny effect, so [[genetic-enhancement-of-intelligence]] by editing is not a near-term prospect regardless of legality. Even apparently simple protective variants carry pleiotropic costs: disrupting CCR5 confers partial HIV resistance and also increases susceptibility to West Nile virus. The realistic near-term worry about enhancement is confident intervention on the basis of incomplete genetics rather than superhuman children, an error mode that [[designer-babies]] discussions frequently understate and that ethicists working on [[procreative-beneficence]] and [[disability-rights-and-enhancement]] have examined from opposite directions. ### What would have to change### What would have to change removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
143 lines are the same in both revisions, and 83 of them are not shown. Neither revision here is necessarily the current article — read Human germline editing for the text this wiki stands behind today.